Options
Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction
ISSN
0008-6363
Date Issued
2014
Author(s)
Unsoeld, Bernhard W.
Kaul, Axel
Sbroggi, Mauro
Schubert, Carola
Regitz-Zagrosek, Vera
Brancaccio, Mara
Damilano, Federico
Hirsch, Emilio
Bilsen, Marc van
Munts, Chantal
Sipido, Karin
Bito, Virginie
Detre, Elke
Wagner, Nana Maria
Vogt, Johannes
Neef, Stefan
Balligand, Jean Luc
Bouzin, Caroline
Ventura-Clapier, Renee
Garnier, Anne
Knoell, Ralph
Tarone, Guido
DOI
10.1093/cvr/cvt235
Abstract
Melusin is a muscle-specific chaperone protein whose expression is required for a compensatory hypertrophy response to pressure overload. Here, we evaluated the consequences of melusin overexpression in the setting of myocardial infarction (MI) using a comprehensive multicentre approach. Mice overexpressing melusin in the heart (TG) and wild-type controls (WT) were subjected to permanent LAD ligation and both the acute response (Day 3) and subsequent remodelling (2 weeks) were examined. Mortality in wild-type mice was significant between Days 3 and 7, primarily due to cardiac rupture, but melusins overexpression strongly reduced mortality (43.2 in wild-type vs. 27.3 in melusin-TG, P 0.005). At Day 3 after MI, a time point preceding the mortality peak, TG hearts had increased heat shock protein 70 expression, increased ERK1/2 signalling, reduced cardiomyocyte hyper-contractility and inflammatory cell infiltrates, and increased matricellular protein expression in the infarcted area. At 2 weeks after MI, melusin overexpression conferred a favourable adaptive remodelling characterized by reduced left ventricle dilatation and better preserved contractility in the presence of a comparable degree of hypertrophy. Adaptive remodelling in melusin TG mice was characterized by reduced apoptosis and fibrosis as well as increased cardiomyocyte contractility. Consistent with its function as a chaperone protein, melusin overexpression exerts a dual protective action following MI reducing an array of maladaptive processes. In the early phase after MI, reduced inflammation and myocyte remodelling protect against cardiac rupture. Chronically, reduced myocyte loss and matrix remodelling, with preserved myocyte contractility, confer adaptive LV remodelling.